From Information Overload to Actionable Insights: How a National Cancer Research Center Identifies Meaningful Mutations in Somatic Tumor Testing

Watch a 43-minute webinar featuring Dr. Ana Krivokuca, founder and Head of the Department for genetic counseling at the Institute for Oncology and Radiology of Serbia, as she explores how national cancer research centers navigate the challenges of next-generation sequencing (NGS) data interpretation. Learn how precision medicine is revolutionizing cancer care through NGS testing, while addressing the growing complexity of variant interpretation that challenges both oncologists and laboratories. Discover how the Institute for Oncology and Radiology of Serbia implements the Human Somatic Mutation Database (HSMD) in their NGS testing pipeline to effectively validate and assess the clinical significance of detected variants. Gain insights into how HSMD, a QIAGEN somatic database, combines expert-curated content with data from over 300,000 clinical oncology cases to provide comprehensive genomic insights for tumor characterization, treatment options, and gene panel development.